Sulfated CXCR3 Peptide Trap Use as a Promising Therapeutic Approach for Age-Related Macular Degeneration.
Gukheui JoJae-Byoung ChaeSun-Ah JungJungmook LyuHyewon ChungJoon H LeePublished in: Biomedicines (2024)
These findings demonstrate that the sulfated form of the CXCR3 peptide trap is a valuable tool that could be supplemented with antivascular endothelial growth factors in AMD treatment.